Nebumed Pharma Llp - Company Profile

It is a business services limited liability partnership based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Nebumed Pharma Llp

Nebumed Pharma Llp, a struck off limited liability partnership, was established on 08 February 2016 in Mumbai, Maharashtra, India. Engaging in other services within the business services sector, it holds LLPIN: AAF-6608. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹3.75 Cr.

Its leadership includes Shirin Hamied (Partner), Rumana Hamied (Partner), Shonaal Amar Lulla (Partner). Past directors included Raman Parameswaran Athipotta. Its latest date of accounts and solvency statement 31 March 2018. It is based at 1 St Floor, Hornby View Bldg., 12, Rustom Sidhwa Marg, Fort., Mumbai, Maharashtra, 400001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAF-6608

  • Incorporation Date

    08 February 2016

  • Total Obligation of Contribution

    ₹3.75 Cr

  • ROC Code

    Roc Mumbai

  • Company Status

    Struck Off

Key Metrics
  • Obligation of Contribution ₹ 3.75 Cr
  • Company Age 10 Year, 1 Month
  • Last Filing with ROC 31 Mar 2018
Company report

Nebumed Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nebumed Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nebumed Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Shirin Hamied Partner 08 Feb 2016 Current
Rumana Hamied Partner 08 Feb 2016 Current
Shonaal Amar Lulla Partner 08 Feb 2016 Current
Srinivas Hariharan Designated Partner 08 Feb 2016 Current
Geeta Amar Lulla Partner 08 Feb 2016 Current
Shankar Srinivasan Designated Partner 15 Mar 2017 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 14 Mar 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nebumed Pharma Llp.

Enhance accessibility to Nebumed Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nebumed Pharma Llp revenue growth over time
Nebumed Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nebumed Pharma Llp?

Unlock access to Nebumed Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nebumed Pharma Llp?

Unlock and access historical data on people associated with Nebumed Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nebumed Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nebumed Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nebumed Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Nebumed Pharma Llp last Annual general meeting of members was held on 31 Mar 2018 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Nebumed Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was documented.

  • Director Appointment

    Shankar Srinivasan was appointed as a Designated Partner was appointed as a Designated Partner on 15 Mar 2017 & has been associated with this company since 9 years 13 days . was recorded as a recent event.

  • Director Appointment

    The activity Shirin Hamied was appointed as a Partner was appointed as a Partner on 08 Feb 2016 & has been associated with this company since 10 years 1 month . was completed.

  • Director Appointment

    Progress on Rumana Hamied was appointed as a Partner was appointed as a Partner on 08 Feb 2016 & has been associated with this company since 10 years 1 month . was documented.

  • Director Appointment

    The activity Shonaal Amar Lulla was appointed as a Partner was appointed as a Partner on 08 Feb 2016 & has been associated with this company since 10 years 1 month . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Nebumed Pharma Llp?

The LLPIN of Nebumed Pharma Llp is AAF-6608.

Where is Nebumed Pharma Llp headquartered?

Nebumed Pharma Llp is headquartered at 1 St Floor, Hornby View Bldg., 12, Rustom Sidhwa Marg, Fort., Mumbai, Maharashtra, 400001.

When was Nebumed Pharma Llp incorporated?

Nebumed Pharma Llp was incorporated on 08 February 2016.

Who are the current directors of Nebumed Pharma Llp?

The current directors of Nebumed Pharma Llp are

What is the primary industry of Nebumed Pharma Llp?

The primary industry of Nebumed Pharma Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available